7,223 Shares in Intuitive Surgical, Inc. $ISRG Bought by Third View Private Wealth LLC

Third View Private Wealth LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,223 shares of the medical equipment provider’s stock, valued at approximately $4,091,000.

Several other institutional investors have also bought and sold shares of ISRG. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. boosted its position in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical in the third quarter worth $27,000. Olistico Wealth LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $28,000. Finally, Caitlin John LLC purchased a new position in Intuitive Surgical in the third quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on ISRG. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research report on Wednesday, March 11th. Argus cut their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. The Goldman Sachs Group cut their price objective on Intuitive Surgical from $714.00 to $609.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Evercore cut their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research report on Monday, April 6th. Finally, BTIG Research reissued a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $604.73.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $458.96 on Tuesday. The stock’s 50-day simple moving average is $480.39 and its 200 day simple moving average is $514.80. The stock has a market capitalization of $162.99 billion, a price-to-earnings ratio of 58.17, a price-to-earnings-growth ratio of 3.52 and a beta of 1.68. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.